ReviewGynecology and minimally invasive therapy
The Significant Risk Factors of Intra-Operative Hemorrhage during Laparoscopic Myomectomy: A Systematic Review.
Review in Gynecology and minimally invasive therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05806307 (Comparing the Effectiveness of Misoprostol, Oxytocin, Carbetocin, Vasopressin, Bupivacaine and Epinephrine, Combined IV TXA Acid and Ethamsylate and Peri Cervical Tourniquet for the Reduction of Blood Loss During of Abdominal Myomectomy.), which is not on this map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparing the Effectiveness of Misoprostol, Oxytocin, Carbetocin, Vasopressin, Bupivacaine and Epinephrine, Combined IV TXA Acid and Ethamsylate and Peri Cervical Tourniquet for the Reduction of Blood Loss During of Abdominal Myomectomy.
Who cites it
19 citing papers in PubMed, 34 citations in OpenAlex.
- Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.PloS one · 2020Trial
- The Impact of Contained Versus Uncontained Morcellation Following Laparoscopic Myomectomy on Operation Time, Pain Perception and Bleeding.The journal of obstetrics and gynaecology research · 2026Article
- Artificial intelligence for instance segmentation of MRI: advancing efficiency and safety in laparoscopic myomectomy of broad ligament fibroids.Frontiers in oncology · 2025Article
- Laparoscopic myomectomy without uterine manipulator for maintaining endometrial cavity integrity.Heliyon · 2024Article
- How safe is high-intensity focused ultrasound? An intriguing solution for obstetric and gynecological diseases: A systematic review.Turkish journal of obstetrics and gynecology · 2024Article
- Currently Available Treatment Modalities for Uterine Fibroids.Medicina (Kaunas, Lithuania) · 2024Review
- The effects of laparoscopic myomectomy and open surgery on uterine myoma patients' postoperative immuno-inflammatory responses, endocrine statuses, and prognoses: a comparative study.American journal of translational research · 2021Article
- Correlation between Pelvic Diameter and Different Surgical Procedures for Exogenous Cervical Leiomyoma.Gynecology and minimally invasive therapyArticle
- Myomectomy: Choosing the Surgical Approach - A Systematic Review.Gynecology and minimally invasive therapyReview
- Laparoscopic Enucleation of a Cervical Myoma and Reconstruction of Cervical Canal.Gynecology and minimally invasive therapyArticle
- Tips and Tricks for Laparoscopic Myomectomy: A Video Presentation.Gynecology and minimally invasive therapyArticle
- Cold Scissors and Small Myotomy: A Laparoscopic Intracapsular Myomectomy Method for Women in Reproductive Age.Gynecology and minimally invasive therapyArticle
- Analysis of Pregnancy Outcomes and Influencing Factors in Patients with Uterine Fibroids after High-intensity Focused Ultrasound Ablation.Gynecology and minimally invasive therapyArticle
- Treatment Options for Uterine Fibroids Using Microwave and Radiofrequency.Gynecology and minimally invasive therapyReview
- A Journey from Learning a Noninvasive High-intensity Focused Ultrasound Surgical Treatment for Gynecological Diseases to Providing High-intensity Focused Ultrasound Services in Hong Kong.Gynecology and minimally invasive therapyArticle
- Metastatic Smooth Muscle Tumor of Uncertain Malignant Potential after Laparoscopic Presuming Myomectomy.Gynecology and minimally invasive therapyArticle
- Establish the Certification System of Gynecologic Endoscopists.Gynecology and minimally invasive therapyArticle
- High-intensity Focused Ultrasound for the Treatment of Fibroids: A Single-center Experience in Singapore.Gynecology and minimally invasive therapyArticle
- High-intensity Focused Ultrasound is a Better Choice for Women with Fertility Desire: A Systematic Review and Meta-analysis of the Comparison between High-intensity Focused Ultrasound and Laparoscopic Treatment of Uterine Fibroids.Gynecology and minimally invasive therapyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laparoscopic myomectomy (LM) is becoming increasingly common in the management of uterine myomas and is usually offered regardless of the number, location, and size of the myomas. It has a generally low rate of periprocedural complications and is preferred to laparotomy for several reasons that are not limited to decreased length of hospital stay, number of sutures, smaller incisions, and decreased pain. However, blood loss during LM remains a challenge. To be able to stratify patients and provide better management after LM, it is crucial to identify these predictors of blood loss. Therefore, the aim of this review was to identify the risk factors for periprocedural blood loss after laparoscopic uterine myomectomy. According to our data synthesis, age, body mass index, and phase of the menstrual cycle do not seem to affect the blood loss during LM. Conversely, size and number of myomas, as well as operative time, was directly related to the increase of blood loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.